Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..3 of 3 -
per page
Order by
We are focused on licensing or acquiring new, late-stage technologies or existing prescription or OTC dermatology products
More
Strategic divestments of primary care sales focussed brands
More
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets
More
Displaying 1..3 of 3 -
per page
Order by
Nov 2010 - 40 pages - $500
Nov 2011 - 7 pages - $3,835
Jun 2006 - 1458 pages - $2,495
Oct 2009 - 17 pages - $500
Oct 2011 - 150 pages - $3,500
Dec 2010 - 28 pages - $500
Mar 2011 - 32 pages - $250
Mar 2010 - 39 pages - $2,000
Feb 2011 - 26 pages - $1,000